Bruker | BRKR - Cash And Equivalent


Bruker reported $184.9M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
ABB USD 3.87B 542M Jun/2026
Agilent USD 1.76B 49M Jun/2026
Ametek USD 495.45M 14.2M Jun/2026
Bio Techne USD 264.71M 54.89M Jun/2026
Bio-Rad Laboratories USD 517M 9.8M Jun/2026
Bruker USD 184.9M 51.5M Jun/2026
Charles River Laboratories USD 192.02M 195K Jun/2026
Danaher USD 4.35B 1.35B Jun/2026
Fujikura JPY 181.22B 27.23B Mar/2026
Furukawa JPY 21.05B 5.58B Mar/2026
General Electric Aerospace USD 9.35B 1.64B Jun/2026
Hitachi JPY 1.32T 44.54B Mar/2026
Illumina USD 1.09B 329M Mar/2026
IQVIA Holdings USD 1.91B 38M Jun/2026
Mettler Toledo International USD 51.38M 9.19M Jun/2026
Mitsubishi Electric JPY 731.61B 131.23B Mar/2026
Mitsubishi Heavy Industries JPY 1.33T 618.78B Mar/2026
Myriad Genetics USD 115.2M 9.2M Jun/2026
Nikon Corporation JPY 158.04B 6.7B Mar/2026
Olympus JPY 147.24B 93.98B Sep/2025
Repligen USD 606.78M 24.13M Jun/2026
Revvity USD 1.02B 162.62M Jun/2026
Smiths GBP 345M 47M Dec/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Waters USD 539M 77M Jun/2026